Medpace Holdings, Inc. (MEDP)
NASDAQ: MEDP · Real-Time Price · USD
312.36
-4.25 (-1.34%)
At close: Mar 28, 2025, 4:00 PM
311.26
-1.10 (-0.35%)
Pre-market: Mar 31, 2025, 8:42 AM EDT
Medpace Holdings Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for Medpace Holdings stock have an average target of 373.22, with a low estimate of 330 and a high estimate of 435. The average target predicts an increase of 19.48% from the current stock price of 312.36.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Medpace Holdings stock from 10 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 4 | 4 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 5 | 5 | 5 | 5 | 5 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Leerink Partners | Leerink Partners | Hold Initiates $330 | Hold | Initiates | $330 | +5.65% | Mar 24, 2025 |
| Baird | Baird | Hold Maintains $354 → $362 | Hold | Maintains | $354 → $362 | +15.89% | Jan 27, 2025 |
| Baird | Baird | Hold Maintains $349 → $354 | Hold | Maintains | $349 → $354 | +13.33% | Nov 25, 2024 |
| TD Cowen | TD Cowen | Strong Buy Maintains $413 → $372 | Strong Buy | Maintains | $413 → $372 | +19.09% | Oct 23, 2024 |
| Baird | Baird | Buy → Hold Downgrades $413 → $349 | Buy → Hold | Downgrades | $413 → $349 | +11.73% | Oct 23, 2024 |
Financial Forecast
Revenue This Year
2.21B
from 2.11B
Increased by 4.64%
Revenue Next Year
2.42B
from 2.21B
Increased by 9.74%
EPS This Year
12.62
from 12.63
Decreased by -0.09%
EPS Next Year
14.11
from 12.62
Increased by 11.80%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 2.3B | 2.6B | 3.0B | ||
| Avg | 2.2B | 2.4B | 2.7B | ||
| Low | 2.1B | 2.3B | 2.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.9% | 17.9% | 22.5% | ||
| Avg | 4.6% | 9.7% | 12.1% | ||
| Low | -0.3% | 2.2% | 2.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 13.24 | 15.03 | 17.81 | ||
| Avg | 12.62 | 14.11 | 16.30 | ||
| Low | 11.88 | 13.24 | 15.12 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.8% | 19.1% | 26.2% | ||
| Avg | -0.1% | 11.8% | 15.5% | ||
| Low | -6.0% | 4.9% | 7.2% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.